SPONSOR
Haisco Pharmaceutical Group Co., Ltd.
Total Trials
7
Recruiting
7
Phases
Phase 1, Phase 2, Phase 3
Conditions studied: Solid Tumors (Phase 1)NSCLCNon-cystic Fibrosis Bronchiectasis (NCFBE)Lupus Nephritis (LN)IgA Nephropathy (IgAN)Non-cystic Fibrosis BronchiectasisParoxysmal Nocturnal Hemoglobinuria (PNH)
Haisco Pharmaceutical Group Co., Ltd. is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Solid Tumors (Phase 1), NSCLC, Non-cystic Fibrosis Bronchiectasis (NCFBE), Lupus Nephritis (LN).
The trial portfolio spans Phase 1, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Haisco Pharmaceutical Group Co., Ltd.
How many clinical trials has Haisco Pharmaceutical Group Co., Ltd. sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by Haisco Pharmaceutical Group Co., Ltd., of which 7 are actively recruiting participants. These trials cover conditions including Solid Tumors (Phase 1), NSCLC, Non-cystic Fibrosis Bronchiectasis (NCFBE). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Haisco Pharmaceutical Group Co., Ltd. research focus on?
Haisco Pharmaceutical Group Co., Ltd. clinical trials span Solid Tumors (Phase 1), NSCLC, Non-cystic Fibrosis Bronchiectasis (NCFBE), Lupus Nephritis (LN), IgA Nephropathy (IgAN), and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Haisco Pharmaceutical Group Co., Ltd. clinical trial?
To participate in a Haisco Pharmaceutical Group Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Haisco Pharmaceutical Group Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Haisco Pharmaceutical Group Co., Ltd.
NCT07561554 Phase 1
Recruiting
Phase I Study of HSK42360-Na in Solid Tumors With BRAF V600 Mutation
Solid Tumors (Phase 1)
NCT06050980 Phase 1
Recruiting
Phase I Study of HSK40118 in NSCLC Patients With EGFR Mutation
NSCLC
NCT07915024 Phase 1
Recruiting
Phase 1 Study to Assess the Effects of HSK31858 on the QT/QTc Interval in Healthy Chinese Participants
Non-cystic Fibrosis Bronchiectasis (NCFBE)
NCT07363460 Phase 2
Recruiting
Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN
Lupus Nephritis (LN)
NCT07390123 Phase 3
Recruiting
Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN
IgA Nephropathy (IgAN)
NCT07616375 Phase 3
Recruiting
A Study to Assess the Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis
Non-cystic Fibrosis Bronchiectasis
NCT07152288 Phase 1
Recruiting
Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HSK39297 in Subjects With Hepatic Impairment
Paroxysmal Nocturnal Hemoglobinuria (PNH)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology